Introducing the all-new Philips IntraSight interventional applications platform where imaging, physiology, co-registration* and software come together to facilitate optimal patient care. IntraSight offers a comprehensive suite of clinically proven modalities, such as, iFR/FFR, IVUS and co-registration* to simplify complex interventions, speed routine procedures and provide improved patient care.
As the number of cardiovascular and vascular patients grows, so does the need to work smarter and faster. Philips IntraSight offers you these best-in-class interventional tools allowing you to see clearly so you can make fast, informed clinical decisions that may lead to optimal treatment plans. Integrating the most advanced physiology and imaging platform into your workflow should be smart, simple and seamless.
IntraSight is the only interventional platform that:
For customers with non-Philips interventional suites, IntraSight 7 offers seamless integration and full use of our interventional applications. IntraSight 7 promotes enhanced workflow management with the tableside touch screen module allowing for ease of use and access to best in class interventional tools such as iFR/FFR, IVUS and co-registration. Additionally, IntraSight 7 integration with non-Philips interventional suites allows customers to benefit from intuitive solutions such as, vessel enhancement and device detection, ultimately allowing all customers to benefit from IntraSight 7’s comprehensive offering of smart solutions without compromise.
Digital IVUS
imaging
Delivering an outstanding user experience with a modern,
intuitive interface that minimizes learning curves and
increases workflow confidence.
Easy-to-use because you can:
Optimizing lab performance with tableside touchscreen control, systems integration, data management and remote service diagnostics
Increase case efficiency, save time and reduce errors with seamless data
IntraSight interventional applications platform configurations provide interventional excellence to help you see clearly and treat optimally.
#futureofIGT, #futureofCAD, #IntraSight #CoronaryIntervention, #seeclearlytreatoptimally, #IVUS
How would you improve interventional procedures?
What do you think about the new IntraSight platform?
Are we on the right track?
Connect with us via #futureofIGT / #IntraSight
Fabienne van der Feer
fabienne.van.der.feer@philips.com
Phone: +31 622 698 001
Mark Groves
mark.groves@philips.com
Phone: +31 631 639 916
* Co-registration tools available within IntraSight 7 configuration via SyncVision.
1. Davies JE, et al., Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.
2. Gotberg M, et al., iFR-SWEDEHEART Investigators.. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11; 376(19):1813-18233.
3. Bhatt D, Assessment of Stable Coronary Lesions. N Engl J Med. 2017 May 11;376(19):1879-1881.
4. ACC CathPCI Hospital Registry.
5. Lofti A, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions. Catheter Cardiovasc Interv. 2018;1–12.
6. 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.
